Success Metrics

Clinical Success Rate
84.6%

Based on 11 completed trials

Completion Rate
85%(11/13)
Active Trials
6(22%)
Results Posted
36%(4 trials)
Terminated
2(7%)

Phase Distribution

Ph phase_4
3
11%
Ph not_applicable
16
59%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution19 total trials
Phase 4Post-market surveillance
3(15.8%)
N/ANon-phased studies
16(84.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.6%

11 of 14 finished

Non-Completion Rate

21.4%

3 ended early

Currently Active

6

trials recruiting

Total Trials

27

all time

Status Distribution
Active(9)
Completed(11)
Terminated(3)
Other(4)

Detailed Status

Completed11
Recruiting4
unknown4
Active, not recruiting2
Terminated2
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
27
Active
6
Success Rate
84.6%
Most Advanced
Phase 4

Trials by Phase

Phase 43 (15.8%)
N/A16 (84.2%)

Trials by Status

withdrawn14%
completed1141%
active_not_recruiting27%
recruiting415%
terminated27%
unknown415%
not_yet_recruiting27%
enrolling_by_invitation14%

Recent Activity

Clinical Trials (27)

Showing 20 of 27 trialsScroll for more
NCT07423065Not Applicable

The Impact of Continuous Glucose Monitoring on Glucose Variability and Weight Loss in Individuals With Prediabetes and Obesity

Recruiting
NCT04416269Phase 4

Oral Anti Diabetic Agents in the Hospital

Terminated
NCT07743307Not Applicable

Feasibility of a Diabetes Self-Management Program With Continuous Glucose Monitoring for Adults With Type 2 Diabetes

Enrolling By Invitation
NCT07278531Not Applicable

Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes

Not Yet Recruiting
NCT05000021Not Applicable

Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes

Active Not Recruiting
NCT07595289Not Applicable

DP-DCT 1.0:A Comparative Clinical Study on the Effect of Dapagliflozin Combined With CGM Versus SMBG on Glycemic Control in Patients With Type 2 Diabetes Mellitus Based on the DP-DCT Platform

Not Yet Recruiting
NCT07135531Not Applicable

Continuous Glucose Monitoring (CGM) in an Underserved Population

Recruiting
NCT05639556

Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF

Active Not Recruiting
NCT06471322Not Applicable

A Multi-Disciplinary Technology-Based Care for Diabetic Ketoacidosis in Patients With Type 1 Diabetes

Terminated
NCT05734313Not Applicable

Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression

Recruiting
NCT03436212Not Applicable

Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.

Completed
NCT06630637Not Applicable

Monitoring Intermittent Fasting for Human Optimization Using Wearable Technology: An N-of-1 Study

Completed
NCT05516797Not Applicable

IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE)

Completed
NCT04605497Not Applicable

Time-in-range Using Continuous Glucose Monitoring Management of Gestational Diabetes Mellitus

Completed
NCT05335889

Wearable Sensors and Artificial Intelligence for Carbohydrate Counting

Completed
NCT05741489Not Applicable

Continuous Glucose Monitoring in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes

Completed
NCT05509881Not Applicable

Continuous Glucose Monitoring in Dialysis Patients to Overcome Dysglycemia Trial

Recruiting
NCT01049152

Continuous Glucose Monitoring and Inflammation in Nondiabetic and Diabetic Patients Undergone Hemodialysis

Completed
NCT03340831

Continuous Monitoring and Control of Hypoglycemia

Unknown
NCT04559191Phase 4

Atheroma Progression and Vulnerability Under Continuous Glucose Monitoring

Unknown

Drug Details

Intervention Type
DEVICE
Total Trials
27